TY - JOUR
T1 - Prevalence of common fusion genes among Thai pediatric patients with B-cell acute lymphoblastic leukemia
AU - Sriprach, Suwimon
AU - Takpradit, Chayamon
N1 - Publisher Copyright:
© 2024, Thai Red Cross Society National Blood Center. All rights reserved.
PY - 2024/7/1
Y1 - 2024/7/1
N2 - Background: Identifying genetic alterations among patients with B-cell acute lymphoblastic leukemia (B-ALL) is required for risk classification, prognosis and tailored therapy to avoid relapse. Methods: Reverse transcription-polymerase chain reaction (RT-PCR) was performed to determine the prevalence of 4 common fusion genes for B-ALL: ETV6-RUNX1, TCF3-PBX1, BCR-ABL1 and MLL-AF4. Bone marrow samples from 145 Thai patients with de novo B-ALL, aged between 0 and 18 years, were analyzed. Results: Thirty-eight cases (26.2%) were positive for the 4 common fusion genes. The prevalence of ETV6-RUNX1, TCF3-PBX1, BCR-ABL1 and MLL-AF4 was 11.7, 9.7, 4.1 and 0.7% respectively. No co-expression of 2 fusion genes was observed. The distribution of the 4 common fusion genes among age groups showed no significant difference (p = 0.944). MLL-AF4 was detected only in an infant, while BCR-ABL1 was not found among adolescents (p = 0.030). TCF3-PBX1 and BCR-ABL1 were significantly associated with central nervous system involvement (p = 0.028). Most patients with BCR-ABL1 and MLL-AF4 had comparable cytogenetic test results, whereas patients with ETV6-RUNX1 and TCF3-PBX1 did not. Conclusion: Regarding 4 common fusion genes, ETV6-RUNX1 and TCF3-PBX1 were predominantly seen among B-ALL patients. RT-PCR is a precise tool to detect fusion genes, but chromosome testing remains inadequate. More extensive studies and broader tests involving more fusion genes are needed.
AB - Background: Identifying genetic alterations among patients with B-cell acute lymphoblastic leukemia (B-ALL) is required for risk classification, prognosis and tailored therapy to avoid relapse. Methods: Reverse transcription-polymerase chain reaction (RT-PCR) was performed to determine the prevalence of 4 common fusion genes for B-ALL: ETV6-RUNX1, TCF3-PBX1, BCR-ABL1 and MLL-AF4. Bone marrow samples from 145 Thai patients with de novo B-ALL, aged between 0 and 18 years, were analyzed. Results: Thirty-eight cases (26.2%) were positive for the 4 common fusion genes. The prevalence of ETV6-RUNX1, TCF3-PBX1, BCR-ABL1 and MLL-AF4 was 11.7, 9.7, 4.1 and 0.7% respectively. No co-expression of 2 fusion genes was observed. The distribution of the 4 common fusion genes among age groups showed no significant difference (p = 0.944). MLL-AF4 was detected only in an infant, while BCR-ABL1 was not found among adolescents (p = 0.030). TCF3-PBX1 and BCR-ABL1 were significantly associated with central nervous system involvement (p = 0.028). Most patients with BCR-ABL1 and MLL-AF4 had comparable cytogenetic test results, whereas patients with ETV6-RUNX1 and TCF3-PBX1 did not. Conclusion: Regarding 4 common fusion genes, ETV6-RUNX1 and TCF3-PBX1 were predominantly seen among B-ALL patients. RT-PCR is a precise tool to detect fusion genes, but chromosome testing remains inadequate. More extensive studies and broader tests involving more fusion genes are needed.
KW - B-ALL
KW - Fusion genes
KW - Pediatric
KW - Prevalence
KW - Thailand
UR - https://www.scopus.com/pages/publications/105054008144
U2 - 10.69898/jhtm.v34i3.271167
DO - 10.69898/jhtm.v34i3.271167
M3 - Article
AN - SCOPUS:105054008144
SN - 2985-2390
VL - 34
SP - 195
EP - 203
JO - Journal of Hematology and Transfusion Medicine
JF - Journal of Hematology and Transfusion Medicine
IS - 3
ER -